A citation-based method for searching scientific literature


List of co-cited articles
95 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
183
41

Ductal carcinoma in situ - update on risk assessment and management.
Jia-Min B Pang, Kylie L Gorringe, Stephen B Fox. Histopathology 2016
28
33

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
207
33


Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
170
33

DCIS and axillary nodal evaluation: compliance with national guidelines.
Katrina B Mitchell, Heather Lin, Yu Shen, Alfred Colfry, Henry Kuerer, Simona F Shaitelman, Gildy V Babiera, Isabelle Bedrosian. BMC Surg 2017
22
33

A prognostic index for ductal carcinoma in situ of the breast.
M J Silverstein, M D Lagios, P H Craig, J R Waisman, B S Lewinsky, W J Colburn, D N Poller. Cancer 1996
458
25

SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening.
Stefan O Emdin, Bengt Granstrand, Anita Ringberg, Kerstin Sandelin, Lars-Gunnar Arnesson, Hans Nordgren, Harald Anderson, Hans Garmo, Lars Holmberg, Arne Wallgren. Acta Oncol 2006
159
25

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
422
25

An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.
Stephanie G MacAusland, Jaroslaw T Hepel, Frank K Chong, Shira L Galper, Jennifer S Gass, Robin Ruthazer, David E Wazer. Cancer 2007
58
25


The influence of margin width on local control of ductal carcinoma in situ of the breast.
M J Silverstein, M D Lagios, S Groshen, J R Waisman, B S Lewinsky, S Martino, P Gamagami, W J Colburn. N Engl J Med 1999
475
25

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
430
25

Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
193
25

Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ.
Monica Morrow, Kimberly J Van Zee, Lawrence J Solin, Nehmat Houssami, Mariana Chavez-MacGregor, Jay R Harris, Janet Horton, Shelley Hwang, Peggy L Johnson, M Luke Marinovich,[...]. Pract Radiat Oncol 2016
65
25

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
John F Forbes, Ivana Sestak, Anthony Howell, Bernardo Bonanni, Nigel Bundred, Christelle Levy, Gunter von Minckwitz, Wolfgang Eiermann, Patrick Neven, Michael Stierer,[...]. Lancet 2016
85
25

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
305
25

Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.
Fredrik Wärnberg, Hans Garmo, Stefan Emdin, Veronica Hedberg, Linda Adwall, Kerstin Sandelin, Anita Ringberg, Per Karlsson, Lars-Gunnar Arnesson, Harald Anderson,[...]. J Clin Oncol 2014
101
25

The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.
M Luke Marinovich, Lamiae Azizi, Petra Macaskill, Les Irwig, Monica Morrow, Lawrence J Solin, Nehmat Houssami. Ann Surg Oncol 2016
77
25

Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
Ashleigh M Francis, Christine E Haugen, Lynn M Grimes, Jaime R Crow, Min Yi, Elizabeth A Mittendorf, Isabelle Bedrosian, Abigail S Caudle, Gildy V Babiera, Savitri Krishnamurthy,[...]. Ann Surg Oncol 2015
39
25

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
Lawrence J Solin, Robert Gray, Lorie L Hughes, William C Wood, Mary Ann Lowen, Sunil S Badve, Frederick L Baehner, James N Ingle, Edith A Perez, Abram Recht,[...]. J Clin Oncol 2015
142
25

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
360
25


Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis.
Kirsty E Stuart, Nehmat Houssami, Richard Taylor, Andrew Hayen, John Boyages. BMC Cancer 2015
43
25

International variation in management of screen-detected ductal carcinoma in situ of the breast.
Antonio Ponti, Elsebeth Lynge, Ted James, Ondřej Májek, My von Euler-Chelpin, Ahti Anttila, Patricia Fitzpatrick, Maria Piera Mano, Masaaki Kawai, Astrid Scharpantgen,[...]. Eur J Cancer 2014
26
25

Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.
Mattia Intra, Nicole Rotmensz, Paolo Veronesi, Marco Colleoni, Simona Iodice, Giovanni Paganelli, Giuseppe Viale, Umberto Veronesi. Ann Surg 2008
79
25

Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base.
Megan E Miller, Alexandra Kyrillos, Katharine Yao, Olga Kantor, Jennifer Tseng, David J Winchester, Lawrence N Shulman. Ann Surg Oncol 2016
14
25

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
L M van Roozendaal, B Goorts, M Klinkert, K B M I Keymeulen, B De Vries, L J A Strobbe, C A P Wauters, Y E van Riet, E Degreef, E J T Rutgers,[...]. Breast Cancer Res Treat 2016
34
25

Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situ.
Oyewale O Shiyanbola, Brian L Sprague, John M Hampton, Kim Dittus, Ted A James, Sally Herschorn, Ronald E Gangnon, Donald L Weaver, Amy Trentham-Dietz. Cancer 2016
17
16

The management of ductal carcinoma in situ in North America and Europe. Results of a survey.
Elizabeth Ceilley, Reshma Jagsi, Saveli Goldberg, Lisa Kachnic, Simon Powell, Alphonse Taghian. Cancer 2004
40
16

Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.
Heather R Macdonald, Melvin J Silverstein, Laura A Lee, Wei Ye, Premal Sanghavi, Dennis R Holmes, Howard Silberman, Michael Lagios. Am J Surg 2006
46
16

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
N Bijker, J L Peterse, L Duchateau, J P Julien, I S Fentiman, C Duval, S Di Palma, J Simony-Lafontaine, I de Mascarel, M J van de Vijver. J Clin Oncol 2001
347
16

Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast.
Lawrence J Solin, Alain Fourquet, Frank A Vicini, Marie Taylor, Ivo A Olivotto, Bruce Haffty, Eric A Strom, Lori J Pierce, Lawrence B Marks, Harry Bartelink,[...]. Cancer 2005
122
16

Current view on ductal carcinoma in situ and importance of the margin thresholds: A review.
A Van Cleef, S Altintas, M Huizing, K Papadimitriou, P Van Dam, W Tjalma. Facts Views Vis Obgyn 2014
12
16

Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States.
Charles E Rutter, Henry S Park, Brigid K Killelea, Suzanne B Evans. Ann Surg Oncol 2015
40
16

Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
Karla Kerlikowske, Annette Molinaro, Imok Cha, Britt-Marie Ljung, Virginia L Ernster, Kim Stewart, Karen Chew, Dan H Moore, Fred Waldman. J Natl Cancer Inst 2003
172
16

The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ.
P A Holland, A Gandhi, W F Knox, M Wilson, A D Baildam, N J Bundred. Br J Cancer 1998
63
16


Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
191
16

Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ.
Laura G Estévez, Ana Suarez-Gauthier, Elena García, Cristina Miró, Isabel Calvo, María Fernández-Abad, Mercedes Herrero, Manuel Marcos, Cristina Márquez, Fernando Lopez Ríos,[...]. Breast Cancer Res 2014
8
25

Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS).
Julia S Wong, Yu-Hui Chen, Michele A Gadd, Rebecca Gelman, Susan C Lester, Stuart J Schnitt, Dennis C Sgroi, Barbara J Silver, Barbara L Smith, Susan L Troyan,[...]. Breast Cancer Res Treat 2014
67
16

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
299
16

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Richard G Margolese, Reena S Cecchini, Thomas B Julian, Patricia A Ganz, Joseph P Costantino, Laura A Vallow, Kathy S Albain, Patrick W Whitworth, Mary E Cianfrocca, Adam M Brufsky,[...]. Lancet 2016
85
16


Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast.
Jeremy Thomas, Andrew Hanby, Sarah E Pinder, Graham Ball, Gill Lawrence, Anthony Maxwell, Matthew Wallis, Andrew Evans, Hilary Dobson, Karen Clements,[...]. Eur J Cancer 2014
14
16

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.
Kalliopi P Siziopikou, Stewart J Anderson, Melody A Cobleigh, Thomas B Julian, Douglas W Arthur, Ping Zheng, Eleftherios P Mamounas, Eduardo R Pajon, Robert J Behrens, Janice F Eakle,[...]. Breast Cancer Res Treat 2013
37
16


Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast.
Lars Holmberg, Hans Garmo, Bengt Granstrand, Anita Ringberg, Lars-Gunnar Arnesson, Kerstin Sandelin, Per Karlsson, Harald Anderson, Stefan Emdin. J Clin Oncol 2008
164
16

Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.
Lorie L Hughes, Molin Wang, David L Page, Robert Gray, Lawrence J Solin, Nancy E Davidson, Mary Ann Lowen, James N Ingle, Abram Recht, William C Wood. J Clin Oncol 2009
210
16

Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ.
Ann C Raldow, David Sher, Aileen B Chen, Abram Recht, Rinaa S Punglia. J Clin Oncol 2016
38
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.